Current Research in Translational Medicine

Papers
(The median citation count of Current Research in Translational Medicine is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Machine learning and artificial intelligence in the service of medicine: Necessity or potentiality?53
Thoughts on cartilage tissue engineering: A 21st century perspective35
Role of Nrf2 in rheumatoid arthritis28
Age and vitamin D affect the magnitude of the antibody response to the first dose of the SARS-CoV-2 BNT162b2 vaccine23
Mechanistic insights into the role of pyroptosis in rheumatoid arthritis23
Real world experience of approved chimeric antigen receptor T-cell therapies outside of clinical trials20
A common TMPRSS2 variant has a protective effect against severe COVID-1920
Sex-mediated effects of ACE2 and TMPRSS2 on the incidence and severity of COVID-19; The need for genetic implementation18
Human mesenchymal stromal cells from different tissues exhibit unique responses to different inflammatory stimuli17
Metformin decreased myocardial fibrosis and apoptosis in hyperhomocysteinemia -induced cardiac hypertrophy15
Heparin beyond anti-coagulation13
Extracellular vesicles isolated from mesenchymal stromal cells primed with neurotrophic factors and signaling modifiers as potential therapeutics for neurodegenerative diseases11
Clinical prognosis evaluation of COVID-19 patients: An interpretable hybrid machine learning approach11
Cell therapy for prenatal repair of myelomeningocele: A systematic review10
European wide survey on allogeneic haematopoietic cell transplantation practice for myelofibrosis on behalf of the EBMT chronic malignancies working party10
Identification of serum exosomal miR-98–5p, miR-183–5p, miR-323–3p and miR-19b-3p as potential biomarkers for glioblastoma patients and investigation of their mechanisms9
Advances in adoptive T-cell therapy for metastatic melanoma9
Preclinical study of a DNA vaccine targeting SARS-CoV-29
In silico assessment of binding affinities of three dementia-protective Human Leukocyte Antigen (HLA) alleles to nine human herpes virus antigens9
IFNG-AS1 and MAF4 long non-coding RNAs are upregulated in acute leukemia patients who underwent bone marrow transplantation8
Astaxanthin attenuates acute cerebral infarction via Nrf-2/HO-1 pathway in rats8
Fludarabine and antithymocyte globulin-based conditioning regimen combined with post-transplantation cyclophosphamide for haploidentical allogeneic hematopoietic stem cell transplantation in patients 8
Scaling up human mesenchymal stem cell manufacturing using bioreactors for clinical uses8
Belumosudil with ROCK-2 inhibition: chemical and therapeutic development to FDA approval for the treatment of chronic graft-versus-host disease8
Allogeneic adipose-derived mesenchymal stromal cell transplantation for refractory lupus nephritis: Results of a phase I clinical trial8
CAR-T therapy in solid transplant recipients with post-transplant lymphoproliferative disease: case report and literature review7
Is procalcitonin a part of human immunological response to SARS-CoV-2 infection or “just” a marker of bacterial coinfection?7
A novel tumor inhibitory hybridoma monoclonal antibody with dual specificity for HER3 and HER27
Biological responses to COVID-19: Insights from physiological and blood biomarker profiles7
New scenarios in Vacuoles, E1 enzyme, X linked, Autoinflammatory, Somatic (VEXAS) syndrome: Evolution from myelodysplastic syndrome to acute myeloid leukemia7
Clinical determinants of relapse following CAR-T therapy for hematologic malignancies: Coupling active strategies to overcome therapeutic limitations6
Potential use of ivermectin for the treatment and prophylaxis of SARS-CoV-2 infection6
The use of intrathecal chemotherapy and dexamethasone for secondary prevention of blinatumomab-related neurotoxicity6
In utero treatment of myelomeningocele with allogenic umbilical cord-derived mesenchymal stromal cells in an ovine model6
CAR-T cells targeting IL-1RAP produced in a closed semiautomatic system are ready for the first phase I clinical investigation in humans5
PHF19 inhibition as a therapeutic target in multiple myeloma5
Improved biological performance of human cartilage-derived progenitors in platelet lysate xenofree media in comparison to fetal bovine serum media5
Cryopreserved allogeneic mesenchymal stem cells enhance wound repair in full thickness skin wound model and cattle clinical teat injuries5
Cardiovascular diseases in patients after hematopoietic stem cell transplantation: Systematic review and Meta-analysis5
Exosomal miR-195 in hUC-MSCs alleviates hypoxia-induced damage of trophoblast cells through tissue factor pathway inhibitor 24
Advanced Systemic Mastocytosis with associated haematological neoplasm: Treatment with avapritinib can facilitate successful bridge to allogeneic haematopoietic cell transplant4
Expression and survival analysis of the STAT gene family in diffuse gliomas using integrated bioinformatics4
The fecal microbiota of gravidas with fetal growth restriction newborns characterized by metagenomic sequencing4
Understanding the hematopoietic microenvironment in chronic myeloid leukemia: A concise review4
Selective dysregulation of ABC transporters in methotrexate-resistant leukemia T-cells can confer cross-resistance to cytarabine, vincristine and dexamethasone, but not doxorubicin4
Comparison of mouse, rat and rabbit models for adipose - Derived stem cells (ASC) research4
Intrathecal methotrexate induced myelopathy, rare yet serious complication: A case report and review of the literature4
Does Ibrutinib impact outcomes of viral infection by SARS-CoV-2 in mantle cell lymphoma patients?4
Serum and ascitic fluid interleukin-17 in spontaneous bacterial peritonitis in Egyptian patients with HCV-related liver cirrhosis3
Resolution of bortezomib-associated chalazia/blepharitis after switch to ixazomib: A case report3
Regulatory factors involved in Th17/Treg cell balance of immune thrombocytopenia3
Plasma-derived extracellular vesicles from myocardial infarction patients inhibits tumor necrosis factor-alpha induced cardiac cell death3
In vitro blood brain barrier models: Molecular aspects and therapeutic strategies in glioma management3
The influence of DNMT3A and DNMT3B gene polymorphisms on acute myeloid leukemia risk in a Moroccan population3
Preclinical-to-clinical innovations in stem cell therapies for liver regeneration3
Fetal hemoglobin modulates neurocognitive performance in sickle cell anemia✰,✰✰3
Genetic polymorphisms and risk of MALT lymphoma in Greek population3
HLA and PF4 antibody production after adenoviral vector SARS-CoV-2 vaccination3
Early prediction of renal graft function: Analysis of a multi-center, multi-level data set3
Gene signatures and prognostic values of m6A-related genes in multiple myeloma3
Multiomics and artificial intelligence enabled peripheral blood-based prediction of amnestic mild cognitive impairment3
A potential role of preexisting inflammation in the development of acute myelopathy following CAR T-cell therapy for diffuse large B-cell lymphoma3
FGF10/FGF17 as prognostic and drug response markers in acute myeloid leukemia3
Diagnostic and management strategies for Myeloproliferative Neoplasm-Unclassifiable (MPN-U): An international survey of contemporary practice3
Serum soluble BCMA can be used to monitor relapse of multiple myeloma patients after chimeric antigen receptor T-cell immunotherapy3
APOE ε4 and Alzheimer's disease diagnosis associated differences in L-carnitine, GBB, TMAO, and acylcarnitines in blood and brain3
Clinical features and functions of a novel Lpl mutation C.986A>C (p.Y329S) in patient with hypertriglyceridemia2
Primary prevention of cancer-associated venous thrombosis: Rationale and challenges in clinical practice2
Are we there yet? cellular therapies for cutaneous T cell lymphoma2
Antibodies to calnexin and mutated calreticulin are common in human sera2
Impact of tixagevimab/cilgavimab prophylaxis in patients undergoing allogeneic hematopoietic stem cell transplants and CAR T-cell therapy: A single center experience2
Bone marrow alterations in COVID-19 infection: The root of hematological problems2
Impact of decontamination therapy on gastrointestinal acute graft-versus-host disease after allogeneic hematopoietic cell transplantation in children2
Transcription analysis of a histones modifiers panel coupled with critical tumor suppressor genes displayed frequent changes in patients with AML.2
CLSPN is a potential biomarker associated with poor prognosis in low-grade gliomas based on a multi-database analysis2
Pectins from various sources inhibit galectin-3-related cardiac fibrosis2
Management of Philadelphia chromosome positive acute lymphoblastic leukemia in the current era2
AML-derived extracellular vesicles negatively regulate stem cell pool size: A step toward bone marrow failure2
A preclinical randomized controlled study of ischemia treated with Ginkgo biloba extracts: Are complex components beneficial for treating acute stroke?2
Cytogenetics in the management of hematological malignancies: An overview of alternative technologies for cytogenetic characterization2
Immune restoration therapy for multidrug-resistant CMV disease in an allogenic stem cell transplant recipient2
A novel MPIG6B gene mutation in an adolescent girl with congenital thrombocytopenia and myelofibrosis2
Cytogenetics in the management of myelodysplastic neoplasms (myelodysplastic syndromes, MDS): Guidelines from the groupe francophone de cytogénétique hématologique (GFCH)1
Correlation analysis between virtual and Complement-Dependent-Cytotoxicity crossmatch in a monocenter retrospective series of 118 allografted patients1
Altered platelet functions during treatment with apremilast for psoriatic arthritis: A case report1
Luspatercept for the treatment of congenital sideroblastic anemia: Two case reports1
Lipidomics: An excellent tool for chronic disease detection1
COVID-19 in the context of autologous hematopoietic stem cell transplantation for a patient with autoimmune disease1
Performances of the H-score and the HLH-2004 score in the positive diagnosis of secondary hemophagocytic lymphohistiocytosis1
Cytogenetics in the management of chronic lymphocytic leukemia: Guidelines from the Groupe Francophone de Cytogénétique Hématologique (GFCH)1
A common glomerular transcriptomic signature distinguishes diabetic kidney disease from other kidney diseases in humans and mice1
Cardiovascular risk in a contemporary cohort of patients with myeloproliferative neoplasms’1
Establishment and characterization of a novel breast implant-associated anaplastic large cell lymphoma cell line and PDX model (BIA-XR1) with a unique KRAS mutation1
Fatal acute graft-versus-host disease in Sézary Syndrome treated with Mogamulizumab and hematopoietic cell transplantation1
Actinomycosis in a mandibular necro-osteolytic lesion in a patient with multiple myeloma treated with bisphosphonates1
Genetic diversity and expression profile of Plasmodium falciparum Pf34 gene supports its immunogenicity1
Case report: Carbamazepine-induced thrombocytopenia complicated with severe skin reactions1
Modifying gap junction communication in cancer therapy1
Utility of 18F-FDG PET/CT in medical care of a promyelocytic sarcoma1
Splenic irradiation prior to allogeneic transplant conditioning in myelofibrosis: A pilot experience1
A simple score (Biovid-19) based on biological parameters predicts transfer to intensive care units and death in COVID-19 patients1
Role of next-generation sequencing in acquired amegakaryocytic thrombocytopenic purpura1
Cytogenetics in the management of acute myeloid leukemia and histiocytic/dendritic cell neoplasms: Guidelines from the Groupe Francophone de Cytogénétique Hématologique (GFCH)1
0.27461695671082